Detalles de la búsqueda
1.
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
N Engl J Med;
388(17): 1547-1558, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36912538
2.
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Lancet;
397(10274): 581-591, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581820
3.
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
BJU Int;
130(3): 370-380, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373443
4.
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
Lancet;
395(10232): 1268-1277, 2020 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145825
5.
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer.
Br J Cancer;
123(7): 1063-1070, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669672
6.
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med;
375(15): 1415-1424, 2016 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27626136
7.
Immunocytochemical detection of ERG expression in exfoliated urinary cells identifies with high specificity patients with prostate cancer.
BJU Int;
117(4): 686-96, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471473
8.
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot.
BJU Int;
127(2): 179-181, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33124729
9.
Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes.
Urol Int;
97(4): 373-379, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27595416
10.
Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo.
Int J Cancer;
134(5): 1102-11, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959905
11.
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09).
Lancet Oncol;
14(4): 306-16, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23465742
12.
Patient experience of bladder cancer: A data linkage study.
BJUI Compass;
5(3): 382-388, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481675
13.
The sex gap in bladder cancer survival - a missing link in bladder cancer care?
Nat Rev Urol;
21(3): 181-192, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37604983
14.
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected data.
Contemp Clin Trials;
128: 107162, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36933612
15.
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
NEJM Evid;
2(4): EVIDoa2300018, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320051
16.
Testicular Surveillance Post-Orchidopexy and its Impact on Early Diagnosis of Testicular Cancer.
Indian J Surg Oncol;
11(3): 513-517, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33013137
17.
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.
BMJ Open;
10(9): e036024, 2020 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907896
18.
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Health Technol Assess;
24(37): 1-176, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32773013
19.
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Eur Urol;
77(3): 320-330, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771797
20.
Men's and carers' experiences of care for prostate cancer: a narrative literature review.
Health Expect;
12(3): 301-12, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19754693